SCHEDULE 13G Filed 2026-10-28 Event — SEC 0000070858-26-000536 →

→ Q32 Bio Inc. QTTB

Stake: — Shares: — Class: Common Stock

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 20/100 · Filer 90d Win Rate: 33% · Hist. 90d Edge: +0.8%

Filer track record (4 filings): 33% 90d win rate, +0.8% 90d edge
Elevated short days-to-cover (5.3 DTC)
Short interest building (+21.0% vs prior settlement)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

10 13D/G filings on this issuer

9 other filings besides this one

Filer Track Record

135 filings by this filer

134 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 5.25

5,652,682 shares short · +21.0% vs prior

Other 13D/G Filings on Q32 Bio Inc.

Filed	Form	Filer	Stake	Shares
2026-10-09	SCHEDULE 13G	Frazier Life Sciences Public Fund, L.P.	—	—	view →
2026-07-20	SCHEDULE 13D/A	ORBIMED ADVISORS LLC	—	4,127,987	view →
2026-07-10	SCHEDULE 13G	Boxer Capital Management, LLC	—	—	view →
2026-06-04	SCHEDULE 13G	BIOTECHNOLOGY VALUE FUND L P	—	—	view →
2026-06-01	SCHEDULE 13D/A	ORBIMED ADVISORS LLC	—	4,127,987	view →
2026-05-28	SCHEDULE 13D/A	Atlas Venture Fund X, L.P.	3.60%	864,261	view →
2020-04-20	SC	Flynn James E	—	—	view →
2020-01-31	SC	Flynn James E	—	—	view →
2019-12-30	SC	Flynn James E	—	—	view →

Other Filings by BANK OF AMERICA CORP /DE/

Filed	Form	Issuer	Stake	Shares
2026-10-28	SCHEDULE 13G	CADIZ INC	—	—	view →
2026-10-28	SCHEDULE 13G	USA TODAY Co., Inc.	—	—	view →
2026-10-28	SCHEDULE 13G	Liberty Live Holdings, Inc.	—	—	view →
2026-10-28	SCHEDULE 13G	Jasper Therapeutics, Inc.	—	—	view →
2026-10-28	SCHEDULE 13G	Dine Brands Global, Inc.	—	—	view →
2026-10-15	SCHEDULE 13D/A	Nuveen Minnesota Quality Municipal Income Fund	100.00%	478	view →
2026-10-07	SCHEDULE 13G	ACCENDRA HEALTH INC/VA/	—	—	view →
2026-10-05	SCHEDULE 13D/A	Nuveen Quality Municipal Income Fund	52.50%	7,495	view →
2026-10-02	SCHEDULE 13D/A	Nuveen Municipal Credit Opportunities Fund	50.70%	2,050	view →
2026-09-17	SCHEDULE 13D/A	PIMCO CALIFORNIA MUNICIPAL INCOME FUND	79.40%	1,920	view →
2026-08-26	SCHEDULE 13D/A	PIMCO NEW YORK MUNICIPAL INCOME FUND II	100.00%	760	view →
2026-08-26	SCHEDULE 13D/A	PIMCO MUNICIPAL INCOME FUND II	79.50%	3,860	view →
2026-08-03	SCHEDULE 13G	Total Return Securities Fund	—	—	view →
2026-08-03	SCHEDULE 13G	Fulcrum Therapeutics, Inc.	—	—	view →
2026-08-03	SCHEDULE 13G	CytomX Therapeutics, Inc.	—	—	view →
2026-08-03	SCHEDULE 13G	IREN Ltd	—	—	view →
2026-08-03	SCHEDULE 13G	Inhibrx Biosciences, Inc.	—	—	view →
2026-08-03	SCHEDULE 13G	BLACKROCK CREDIT ALLOCATION INCOME TRUST	—	—	view →
2026-08-03	SCHEDULE 13G	Research Alliance Corp III	—	—	view →
2026-08-03	SCHEDULE 13G	FRANKLIN STREET PROPERTIES CORP /MA/	—	—	view →

Showing 20 of 134

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →